ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
3 announcements with these filters
Sandu Pharmaceuticals scheduled a Board Meeting for August 11, 2026. The meeting will consider the standalone unaudited financial results for the quarter ended June 30, 2026.
Sandu Pharmaceuticals will hold a board meeting on 11 July 2026 to record the MD’s demise and appoint a Managing Director. Trading window is closed for directors.
Sandu Pharmaceuticals Ltd has scheduled a Board Meeting on May 5, 2026. The board will consider approving standalone audited financial results for the quarter and year ended March 31, 2026, and recommend a final dividend. The trading window remains closed until 48 hours after the results announcement.